Inovio Analysts Tackle Coronavirus Vaccine Timeline, Funding, Pipeline After Q1 ReportBenzinga • 05/12/20
Inovio Pharmaceuticals, Inc. (INO) CEO J. Joseph Kim on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/12/20
Does Inovio Pharmaceuticals Have a Successful Track Record of Developing Vaccines?The Motley Fool • 05/07/20
Inovio Is in a Race to Develop a COVID-19 Vaccine, but Can It Possibly Win?The Motley Fool • 05/01/20
Inovio to expand manufacturing of COVID-19 vaccine candidate with new CEPI grantMarket Watch • 04/30/20
Inovio Analysts Project About 24% Upside Potential Amid Optimism On Coronavirus DNA VaccineBenzinga • 04/29/20
Inovio Option Trader Bets $100K That Coronavirus Vaccine Stock Will Double Again By AugustBenzinga • 04/28/20
Inovio Pharmaceuticals, Mesoblast, and Moderna: Are These Red-Hot Biotech Stocks Still a Buy?The Motley Fool • 04/27/20